Healthcare reform questions continue to indirectly impact the pharmaceutical industry. From combatting high drug prices to regulations around biologics and biosimilars, the industry remains in a bit of limbo, at least for now.
For the second quarter of 2017, Zignal Labs media and social intelligence platform analyzed the entire media spectrum for mentions around three of the biggest issues in the pharmaceutical and biotechnology industries -- biologics & biosimilars, pharmaceutical prices and pharmaceutical journalism.
Download Zignal’s Pharmaceutical Industry Report and see:
Which companies had the largest share of voice
Who the top influencers in the pharmaceutical industry are
How the the location of the conversations for pharmaceuticals and biologics differed
Get your free report today and gain insight into what lies ahead for the second half of 2017!
Fill out the form to download the report:
Analyze the entire media spectrum in realtime to make data driven decisions, identify trends and opportunities, and take proactive action.
Stunning visualizations of realtime data enables teams and departments to collaborate across the enterprise.